Unbiased Analysis of Today's Healthcare Issues
Developing drugs is expensive. Some estimates have estimated that the cost of bringing a drug to market is $1 billion. In addition, payers are now reimbursing based on the perceived value of a treatment. That is, treatments that provide more health benefits receive higher reimbursements. In this world of value-based pricing (VBP), pharmaceutical companies have…
In recent years, researchers have created a number of complex simulation models to estimate future trends and the impacts of policy changes. Some of the more prominant models include: RAND Comprehensive Assessment of Reform Efforts (COMPARE) CBO’s Health Insurance Simulation Model (HISim) Urban Institute’s Health Insurance Reform Simulation Model (HIRSM), Future Elderly Model (FEM) These…
The answer is yes, but maybe not as much as you may thought. A paper by Ryan and Bao use data from a randomized controlled trial (RCT) called IMPACT (Improving Mood-Promoting Access to Collaborative Treatment) to determine if errors in physician quality profiling are due mostly to random variation or missing data. For this report,…